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The aim of the study was the evaluation of the inflammatory cytokines within atheromatic carotid plaque.
Materials and methods: The experiment was carried out on 100 symptomatic patients with internal carotid artery
stenosis that underwent carotid endarterectomy. Every patient had the wall of the carotid artery resected during
organ harvesting surgery in order to evaluate some cytokines (TGF-β, VEGF, FGF, TNF-α) and to perform the
immunohistochemistry (IHC). An immunoreactive score (IRS) was calculated based on the staining intensity and the
number of cells stained. Over a 3-year period, 7 patients died, and 2 patients were lost to follow-up. The study group
consisted of 91 patients. The control group comprised 20 young organ donors with confirmed death brain, who had
their normal carotid artery sampled.
Results: In all healthy donors (control group) with normal carotid arteries the three cytokines (TGF-β, VEGF, TNF-α) were
not discovered. The presence of FGF was confirmed in 25% of healthy donors, probably due to an intima fibroblasts
activity, responsible for the synthesis of elastin and collagen to the extracellular matrix (ECM). Only three cytokines
(TGF-β, FGF, TNF-α) were found within atheromatous plaques (study group).
Conclusions: Our research confirmed that these factors may accelerate the development of atheromatic plaque and
its destabilisation.
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(CEA)Background
Cytokines are protein and peptide signaling molecules
used in intercellular communication [1-5]. Cytokines are
characterised both by renundancy (i.e. many cytokines
have similar functions) as well as by pleiotropism [6,7].
They may increase the smooth muscle proliferation by
myocytes as well as synthesis and release of collagen and
elastin to extracellular space by fibroblasts [8]. Such
processes may cause the human atheromatous plaque
enlargement and destabilization, which may lead directly
to stroke [9]. Despite many experimental and clinical
trials it is still an open question which cytokines are* Correspondence: mariusz.chabowski@gmail.com
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the carotid plaque [10].The aim of the study
The comparison of some cytokines concentrations within
atheromatic carotid plaque and normal carotid artery.Methods
Having obtained the approval of the bioethics committee
of the Wroclaw Medical University (No 739/2003), the ex-
periment was carried out on 100 consecutive symptomatic
patients (71 men and 29 women), aged between 46 and
79 years (mean age was 65.5), with critical internal carotid
artery (ICA) stenosis. The authors received written in-
formed patient consents to perform this study. All the pa-
tients had their history taken, had routine biochemistryl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The IHC of the ICA. The presence of the cytokine TGF-ß
(3+, strong reaction) according to the Remmele scale (IRS 12)
(magnification ×200).
Figure 2 The IHC of the ICA. The presence of the cytokine VEGF
(+, weak reaction) according to the Remmele scale (IRS 2)
(magnification ×200).
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ateromatous plaque, the flow parameters and the stage of
carotid stenosis recorded. All the patients had brain CT or
MRI examination. The patients were qualified to surgery
according to NASCET and ECBT standards, i.e. those
having substantial hemodynamic internal carotid artery
stenosis of 70% or more. They underwent carotid end-
arterectomy (CEA) with patch angioplasty or eversion
CEA. All the patients had one or more TIA episodes, 36%
of them had at least one stroke episode, and 64% did not
have any symptoms of a stroke. The patients who were
diagnosed with diabetes or with cancer were excluded
from the study. During the endarterectomy each patient
had the part of internal carotid artery wall excised to
examine the presence of some cytokines: transforming
growth factor (TGF-ß), vascular endothelial growth factor
(VEGF), fibroblast growth factor (FGF), and tumor necro-
sis factor (TNF-α). The immunohistochemistry (IHC) was
performed as well. Over a 3-year period, 7 patients died,
and 2 patients were lost to follow-up. The study group
consisted of 91 patients. All the data were statistically ana-
lyzed by means of the Pearson chi-squared (χ2) test, and
non-parametric Mann–Whitney U test.
The control group consisted of 20 young organ donors
(12 men and 8 women), aged between 20 and 28 years
(mean age was 25) with confirmed death brain by the
brain death committee. During organs harvesting sur-
gery they had their normal internal carotid artery sam-
pled as well.
The presence of the cytokines was assessed by semi-
quantitative immunohistochemical method (antibody/
cytokine) in four step scale: 0, 1+, 2+, 3+ via analysis of
the grade of staining intensity. The immunoreactive
score (IRS) was applied, as described by Remmele and
Stegner (1987). The IRS is the effect of staining inten-
sity: 0 – no reaction (no positive cells), 1–2 weak reac-
tion (<10% positive cells), 3–4 intermediate reaction
(10-50% positive cells), 6–12 strong reaction (>50%
positive cells).
Results
In all healthy donors of the control group the three cyto-
kines (TGF-β, VEGF, TNF-α) were not discovered. In
25% healthy donors (5 people) the presence of FGF was
confirmed by weak positive IHC reaction. In 75% healthy
donors (15 people) the presence of FGF was not found.
In the study group no cytokines was discovered in 10
(11%) patients, and all four cytokines were present in 6
(7%) patients.
As regards TGF-β cytokine: no cytokine was found in
57 (63%) patients, weak reaction was present in 30 pts,
intermediate reaction – in 2 pts, and strong reaction –
in 2 pts (Figure 1). In total TGF-β cytokine was present
in 37% patients.As regards VEGF cytokine: no cytokine was found in
70 (77%) patients, weak reaction was present in 15 pts
(Figure 2), intermediate reaction – in 6 pts, and no
strong reaction was revealed. In total VEGF cytokine
was present in 23% patients.
As regards FGF cytokine: no cytokine was found in 12
(13%) patients (Figure 3), weak reaction was present in
30 pts, intermediate reaction – in 27 pts, and strong re-
action – in 22 pts. In total FGF cytokine was present in
79 (87%) patients. In 49 (54%) pts there was increased
FGF (intermediate or strong) reaction revealed. It should
be remembered that cytokine FGF was present in 25%
donors of the control group as well.
Figure 3 The IHC of the ICA. No cytokine FGF (0, no reaction)
according to the Remmele scale (IRS 0) (magnification ×200).
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55 (60%) patients (Figure 4), weak reaction was present
in 27 pts, intermediate reaction – in 7 pts (Figure 4),
and strong reaction – in 2 pts. In total TNF-α cytokine
was present in 36 (40%) patients.
FGF cytokine was the most frequent cytokine within
the atheromatous ICA wall. On the contrary, the rarest
cytokine was the VEGF. The level of FGF cytokine was
three times as high as the others (TNF-α, TGF-β, and
VEGF).
The presence of some cytokines (TNF-α, TGF-β, FGF,
VEGF) within atheromatous ICA was proved. The
cytokine VEGF accelerates endothelial regeneration.
TNF-α is a cytokine that contributes to a necrosis andFigure 4 The IHC of the ICA. The presence of the TNF-α (2+,
intermediate reaction) according to the Remmele scale (IRS 6)
(magnification ×200).proteolysis processes. The increased level of FGF is due
to endothelial and intimal myofibroblast (myoFb) acti-
vity of the atheromatous ICA. It is responsible for the
synthesis of elastic fibers and collagen, then accumulated
in the atheromatous plaque, leading directly to carotid
stenosis and destabilization of the plaque. The presence
of VEGF was noted in patients with ICA stenosis with-
out ulceration or destabilization of the plaque. On the
contrary, FGF was found in patients with critical ICA
stenosis due to plaque ulceration. TNF-α was noted in
patients with plaque ulcerations, with endothelium and
intima proteolysis, which leads to destabilization of the
plaque. In all the patients the level of FGF correlated
with the stage of the ICA stenosis. TGF-β showed the
strongest and statistically significant correlation with the
level of FGF (R = 0.372). FGF is significantly correlated
with both atheromatous lesions proved in H&E stain
(R = 0.360), as well as advanced plaque (R = 0.301). A
statistically significant correlation was found between
the clinical presentation of TIA, and cytokines (FGF,
TGF-β). TNF-α co-existed with FGF, so it similarly cor-
related with atheromatous lesions in H&E stain, the
stage of the ICA stenosis, and TIA symptoms.
What is the relationship between these cytokines and
clinical presentations?
TGF and TNF-α have been reported to increase after
stroke. A statistically significant correlation between
stroke and the presence of TGF-β (R = 0.453), TNF-α
(R = 0.624), and FGF (R = 0.476) was recorded. A statisti-
cally significant correlation between TIA and the pre-
sence of TGF-β (R = 0.403), TNF-α (R = 0.733), and FGF
(R = 0.618) was also demonstrated. Results reported
herein show no correlation between symptoms and the
levels of VEGF.
A loose connective tissue, of high cellularity, with
spindle-shaped cells, resembling myocytes (myofibro-
blasts and fibroblasts) was found in the atheromatous
plaques with increased level of TGF-β, FGF, TNF-α cyto-
kines, not VEGF. What is more, the large focuses of ne-
crosis, calcium and cholesterol deposits, ulceration and
disruption of the fibrous cap were observed. Fibrinogen
was present within all arterial layers, and the smooth
muscle cells were more frequently found.
Discussion
No cytokines in the ICA wall of the control group may
be a sign of not damaged intima, with no need for re-
generation (VEGF), and no necrosis (TNF-α). The pre-
sence of FGF in some healthy donors was probably due
to an intima fibroblasts activity, responsible for the syn-
thesis of elastic fibers and collagen to the extracellular
matrix (ECM) [11-13]. The continuous arterial blood
pressure interacting on the vessel wall causes the need
of an intima elastic fibers and collagen regeneration
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the FGF in the formation of the primary carotid plaque.
FGF plays an important role in the remodeling of the
extracellular matrix, and therefore may influence the
clinical presentation [17-19]. The statistically significant
impact of TGF-β on FGF has been observed as well.
FGF and TNF-α influence the TIA and stroke occur-
rence, so these cytokines must participate in destabilisa-
tion of carotid plaque.
However, the definitive role of cytokines and the extra-
cellular matrix (ECM) in pathogenesis of peripheral arte-
rial occlusive disease is still unknown [20-23]. Therefore,
there is a need for a further experimental and clinical
studies.
Conclusion
The presence of some cytokins (FGF, TGF-β, and TNF-α)
within atheromatic plaque of the internal carotid artery
stenosis may accelerate the development of atheromatic
plaque and its destabilisation.
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